Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug470 | BIIB091 Wiki | 0.71 |
| drug3252 | Rabeprazole Wiki | 0.71 |
| drug2028 | Itraconazole Wiki | 0.58 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D000542 | Alveolitis, Extrinsic Allergic NIH | 1.00 |
| D006967 | Hypersensitivity, NIH | 0.45 |
| D017563 | Lung Diseases, Interstitial NIH | 0.27 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| HP:0006516 | Hypersensitivity pneumonitis HPO | 1.00 |
| HP:0012393 | Allergy HPO | 0.45 |
| HP:0006515 | Interstitial pneumonitis HPO | 0.27 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| HP:0002088 | Abnormal lung morphology HPO | 0.20 |
| HP:0002090 | Pneumonia HPO | 0.05 |
Navigate: Correlations HPO
There is one clinical trial.
The objective of this study is to administer and validate a disease specific health related quality of life (HRQOL) survey for patients with Chronic Hypersensitivity Pneumonitis (CHP).
Description: The newly developed survey that is being validated consists of 42 items that assess the impact that Hypersensitivity Pneumonitis has on daily life for those who have the disease.
Measure: Validation of a health-related quality of life instrument for patients with Chronic Hypersensitivity Pneumonitis Time: Day 0Description: This survey will be used to assess the validity of the newly developed health-related quality of life instrument. This survey consists of 12 items. The average score for this survey has been calibrated to 50 with scores below 50 indicating a below average score and scores above 50 indicating an above average score.
Measure: Validation of a health-related quality of life instrument for patients with Chronic Hypersensitivity Pneumonitis by administering the Short Form (SF-12) Survey Time: Day 0Description: This survey will be used to assess the validity of the newly developed health-related quality of life instrument. This survey consists of 15 items and is scored from 0-100 with 100 indicating good health.
Measure: Validation of a health-related quality of life instrument for patients with Chronic Hypersensitivity Pneumonitis by administering the King's Brief Interstitial Lung Disease Questionnaire Time: Day 0Description: The newly developed survey will be administered again in 2 weeks following the first assessment.
Measure: Change in Health-related Quality of Life Assessment Score Time: 2 weeks following Day 0Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports